Rankings
▼
Calendar
BDX Q3 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$59B
Q3 2019 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$4.3B
+1.7% YoY
Gross Profit
$2.1B
47.7% margin
Operating Income
$626M
14.4% margin
Net Income
$451M
10.4% margin
EPS (Diluted)
$1.51
QoQ Revenue Growth
+3.7%
Cash Flow
Operating Cash Flow
$933M
Free Cash Flow
$696M
Stock-Based Comp.
$56M
Balance Sheet
Total Assets
$52.2B
Total Liabilities
$30.7B
Stockholders' Equity
$21.5B
Cash & Equivalents
$523M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.3B
$4.3B
+1.7%
Gross Profit
$2.1B
$2.0B
+2.9%
Operating Income
$626M
$512M
+22.3%
Net Income
$451M
$594M
-24.1%
Revenue Segments
Medical
$2.3B
53%
Life Sciences
$1.1B
24%
Interventional
$981M
23%
Geographic Segments
UNITED STATES
$2.4B
56%
Non-US
$1.9B
44%
← FY 2019
All Quarters
Q4 2019 →